NASDAQ · PALI
Palisade Bio, Inc.
$1.19$0.00 (0.0%)
Palisade Bio, Inc.’s quoted price sits in the lower half of its reported 52-week range, 58.39% below the high.
Loading market information…
NASDAQ · RKTO · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Rocket One Inc.’s quoted price sits in the lower half of its reported 52-week range, 78.87% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Rocket One Inc.’s next earnings report is currently expected on Dec 2, 2026, with estimated earnings per share of -$0.15. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Rocket One Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Rocket One Inc. focuses on developing and commercializing AI semiconductor infrastructure. It also develops AI chip and memory hardware engineered for orbital and high-radiation environments, including next generation nanomagnetic AI chip technology. It offers semiconductor infrastructure built around nanomagnetic, and spintronic computing technologies designed to address these constraints at the hardware level. It also offers non-volatile nanomagnetic matrix multiplier architecture for machine learning and AI acceleration and spintronic memory technology with potential applications across defense systems, autonomous platforms, resilient edge compute, and radiation-tolerant space computing. The company was formerly known as Hoth Therapeutics, Inc. and changed its name to Rocket One Inc. in May 2026. The company was incorporated in 2017 and is based in Hoboken, New Jersey.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:03 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| -$0.32+17.95% vs estimate |
| $0.00 |
| Q3 2024 | Nov 12, 2024 | -$0.31-3.33% vs estimate | $0.00 |
|---|
THE ANALYST VIEW
4 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.19$0.00 (0.0%)
Palisade Bio, Inc.’s quoted price sits in the lower half of its reported 52-week range, 58.39% below the high.
$3.31-$0.19 (-5.43%)
BriaCell Therapeutics Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.35% below the high.
$2.85-$0.15 (-5.0%)
Entero Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.2% below the high.
$0.68+$0.00 (+0.22%)
Dare Bioscience, Inc.’s quoted price sits in the lower half of its reported 52-week range, 81.97% below the high.
$3.77+$0.47 (+14.24%)
Lexaria Bioscience Corp.’s quoted price sits in the lower half of its reported 52-week range, 82.55% below the high.
$0.93-$0.04 (-3.99%)
FibroBiologics, Inc. Common Stock’s quoted price sits in the lower half of its reported 52-week range, 90.33% below the high.
$1.89+$0.04 (+2.16%)
Processa Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 81.56% below the high.
$1.42-$0.09 (-5.67%)
Pulmatrix, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.64% below the high.
